QCL Life Science Private Limited
About QCL Life Science Private Limited
Data last updated:
QCL Life Science Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2018PTC114248. Its GSTIN is 32AAACQ5465G1ZK (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Muhammed Sadique and Kuttassery Mohammed Shafeeque.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.41 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹2.76 Lakh (net margin 2%) and EBITDA of ₹7.5 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years and 58% over five years.
Company details
Contact details
QCL Life Science Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo 28 3rd Cross Opp. Narayana Pu College Papamma Lay Ou, T, Bangalore, Karnataka, India – 560016
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of QCL Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of QCL Life Science is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of QCL Life Science Private Limited, buy the company report.
Financials of QCL Life Science Private Limited
FY 2025 filings availableQCL Life Science Private Limited reported revenue of ₹1.41 Cr (up 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 58% over five years, including 39% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of QCL Life Science Private Limited, buy the company report.
Board of directors of QCL Life Science Private Limited
QCL Life Science has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muhammed Sadique | Director | 26 Jun 2018 | 8 Years 4 Months | Current |
| Kuttassery Mohammed Shafeeque Also directs: Vibird International Private Limited | Director | 26 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
QCL Life Science Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syklon Labs Private Limited | ₹1.46 Cr (FY 2025) | -73.0% | Rajkot, Gujarat, India | |||
| Arche Medichem Private Limited | ₹1.45 Cr (FY 2024) | 2.0% | New Delhi, Delhi, India | |||
| Kesar Finechem Private Limited | ₹1.44 Cr (FY 2025) | Gandhinagar, Gujarat, India | ||||
| Alechem India Private Limited | ₹1.43 Cr (FY 2025) | -22.0% | Rajnagar, Rajasthan, India | |||
| Farmado Crop Science Private Limited | ₹1.41 Cr (FY 2024) | 44.0% | Bangalore, Karnataka, India | |||
| QCL Life Science Private Limitedthis company | ₹1.41 Cr (FY 2025) | ₹2.76 Lakh | 2% | 39.0% | Bangalore, Karnataka, India | |
| Bidens Agrovet India Private Limited | ₹1.41 Cr (FY 2025) | 2774.0% | Aurangabad, Maharashtra, India | |||
| Essp Meditek Pvt Ltd | ₹1.41 Cr (FY 2025) | 2.0% | Badlapur, Maharashtra, India | |||
| Prosaic Pharmaceuticals Private Limited | ₹1.38 Cr (FY 2025) | 16.0% | Panvel, Maharashtra, India | |||
| Rishita Healthcare Private Limited | ₹1.38 Cr (FY 2024) | 127.0% | New Delhi, Delhi, India | |||
| Oceanic Dyechem Private Limited | ₹1.38 Cr (FY 2025) | 289.0% | Andherieast, Maharashtra, India |
To see the full peer comparison of QCL Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving QCL Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for QCL Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
QCL Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACQ5465G1ZK | Kerala | Active | 26 Nov 2018 |
To see the full GST registrations and return filing status of QCL Life Science Private Limited, buy the company report.
Recent activity
QCL Life Science Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Kuttassery Mohammed Shafeeque was appointed as Director on 26 Jun 2018.
Frequently asked questions
QCL Life Science is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 June 2018 (8+ years old) and is registered under CIN U24290KA2018PTC114248.
QCL Life Science has 2 current directors:
- Muhammed Sadique - Director
- Kuttassery Mohammed Shafeeque - Director
The latest financial statements of QCL Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of QCL Life Science is 32AAACQ5465G1ZK, registered in Kerala.
The CIN (Corporate Identification Number) of QCL Life Science is U24290KA2018PTC114248. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
QCL Life Science was incorporated on 26 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of QCL Life Science by revenue are Syklon Labs Private Limited, Arche Medichem Private Limited, Kesar Finechem Private Limited, Alechem India Private Limited, Farmado Crop Science Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Kuttassery Mohammed Shafeeque was appointed as Director on 26 Jun 2018. Muhammed Sadique was appointed as Director on 26 Jun 2018.
The registered office of QCL Life Science is at No 28 3rd Cross Opp. Narayana Pu College Papamma Lay Ou, T, Bangalore, Karnataka, India – 560016.
QCL Life Science operates in the chemicals industry, in the manufacturing segment.
QCL Life Science can be reached at its registered office: No 28 3rd Cross Opp. Narayana Pu College Papamma Lay Ou, T, Bangalore, Karnataka, India – 560016.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
